Long-Term Effects of Angiotensin II Receptor Blockade with Valsartan on Carotid Arterial Stiffness and Hemodynamic Alterations in Patients with Essential Hypertension

By Okura Takafumi   Watanabe Sanae   Kurata Mie   Koresawa Mitsuko   Irita Jun   Enomoto Daijiro   Jotoku Masanori   Miyoshi Ken-Ichi   Fukuoka Tomikazu   Higaki Jitsuo  

Clinical and Experimental Hypertension, Vol. 30, Iss. 5, 2008-07 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension

By TRENKWALDER P.   DAHL K.   LEHTOVIRTA M.   MULDER H.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 57-57

Informa Healthcare

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite

Effects of the Angiotensin Receptor Blocker Candesartan on Arterial Stiffness and Markers of Extracellular Matrix Metabolism in Patients with Essential Hypertension

By Sasamura Hiroyuki   Kitamura Yudai   Nakamura Mari   Ryuzaki Munekazu   Saruta Takao  

Clinical and Experimental Hypertension, Vol. 28, Iss. 5, 2006-06 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor Blockade

By RUILOPE LUIS  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite